AstraZeneca will cap inhaler costs at $35 per month
Washington Post
The cost-reduction strategy follows a similar move from Boehringer Ingelheim, a rival in the medical device sector.
https://www.washingtonpost.com/business/2024/03/18/astrazeneca-inhaler-price-cap/